Loading…
Seres Therapeutics, Inc. is projected to rise to $6.29 by 2027, a +25% move from its current price of $5.03. MCRB is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/4/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 5 | $4.85 | $5.03 | $5.22 | -0.03% |
| Aug 6 | $4.77 | $5.03 | $5.29 | -0.05% |
| Aug 7 | $4.72 | $5.03 | $5.35 | -0.08% |
| Aug 8 | $4.67 | $5.02 | $5.41 | -0.10% |
| Aug 9 | $4.63 | $5.02 | $5.45 | -0.13% |
| Aug 10 | $4.59 | $5.02 | $5.49 | -0.15% |
| Aug 11 | $4.56 | $5.02 | $5.53 | -0.18% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $4.56 | $5.02 | $5.53 | -0.18% |
| Week 2 | $4.37 | $5.01 | $5.75 | -0.35% |
| Week 3 | $4.23 | $5.00 | $5.91 | -0.53% |
| Week 4 | $4.12 | $4.99 | $6.06 | -0.70% |
| Week 5 | $4.02 | $4.99 | $6.19 | -0.88% |
| Week 6 | $3.93 | $4.98 | $6.31 | -1.05% |
| Week 7 | $3.85 | $4.97 | $6.41 | -1.23% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Seres Therapeutics, Inc. is a clinical-stage healthcare company focused on developing biotherapeutics for serious diseases.
The company develops SER-155, SER-603, SER-147, and other live biotherapeutic candidates intended to decolonize GI pathogens, enhance GI epithelial barrier integrity, and regulate immune response to prevent bacterial bloodstream infections in patients undergoing allogeneic hematopoietic stem cell transplantation.
Seres Therapeutics, Inc. was incorporated in 2010 and is headquartered in Cambridge, Massachusetts. It was formerly known as Seres Health, Inc. and changed its name to Seres Therapeutics, Inc. in May 2015.
Seres Therapeutics, Inc. (MCRB) is currently trading at $4.97 per share.
Its market capitalization is $48.08M and it ranks 4342 by market cap.
The long-range price outlook in the provided forecast shows a bullish trajectory beginning in the later years, with a 2026 range of $4.97 to $6.68 and steadily higher averages in 2030 ($6.61), 2040 ($11.71), and 2050 ($20.30), plus a max of $44.64 and ROI up to 308.9%.
A major floor 52.6% below — a decisive break under it would weaken the trend.
The nearest floor, 7.6% below — buyers have tended to step in here.
The nearest ceiling, 61.8% above — a clean break opens room to run.
A major ceiling 86.1% above — clearing it would confirm fresh momentum.
Key MCRB support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of MCRB market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $4.78 | Buy | $4.84 | Buy |
| MA 10 | $4.97 | Buy | $5.03 | Sell |
| MA 20 | $5.63 | Sell | $5.48 | Sell |
| MA 50 | $6.47 | Sell | $6.37 | Sell |
| MA 100 | $7.42 | Sell | $7.73 | Sell |
| MA 200 | $11.25 | Sell | $9.91 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 33.14 | Neutral |
| Stoch RSI (14) | 69.36 | Neutral |
| CCI (20) | -68.70 | Neutral |
| Williams %R (14) | -77.50 | Info |
| MACD (12,26,9) | -0.04 | Sell |
| ROC (12) | -11.38 | Sell |
| Bollinger %B (20,2) | 0.30 | Neutral |
| Stochastic %K (14) | 22.50 | Neutral |
| TRIX (15) | -1.16 | Sell |
| Awesome (5,34) | -1.35 | Sell |
| Ultimate (7,14,28) | 26.74 | Buy |
| Momentum (10) | -0.50 | Sell |
| Aroon Osc (25) | -64.00 | Sell |
| Hull MA (9) | 4.65 | Buy |
| ADX (14) | 29.90 | Sell |
| ATR (14) | 0.20 | Info |
The near-term technical picture is bearish, with RSI14 at 30.
The stock trades below key moving averages, with SMA50 at $6.82 and SMA200 at $11.70, indicating ongoing downward pressure relative to longer-term trends.
Support is at $5.11 and resistance at $8.14. The 30-day price range spans from $3.78 to $6.52.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $4.65 | $5.03 | $6.59 | 0% | Neutral | |
| $4.86 | $6.29 | $8.68 | +25% | Bullish | |
| $5.10 | $6.86 | $9.94 | +36% | Bullish | |
| $4.90 | $6.81 | $10.24 | +35% | Bullish | |
| $4.59 | $6.57 | $10.18 | +31% | Bullish | |
| $4.14 | $6.09 | $9.70 | +21% | Bullish | |
| $4.45 | $6.71 | $10.94 | +33% | Bullish | |
| $4.78 | $7.37 | $12.29 | +47% | Bullish | |
| $5.15 | $8.13 | $13.82 | +62% | Bullish | |
| $5.93 | $9.56 | $16.55 | +90% | Bullish | |
| $5.91 | $10.53 | $19.65 | +109% | Bullish | |
| $8.88 | $18.99 | $39.49 | +278% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $4.65 | $5.03 | $6.35 | +0.00% |
| September 2026 | $4.33 | $5.17 | $6.38 | +2.84% |
| October 2026 | $4.08 | $4.92 | $6.15 | -4.98% |
| November 2026 | $4.11 | $4.98 | $6.31 | +1.41% |
| December 2026 | $4.21 | $5.15 | $6.59 | +3.29% |
Click any year to see its month-by-month MCRB forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect MCRB to range from $4.65 to $6.59 through 2026. The $5.03 average target implies a 0% move from current prices. A consolidation phase looks the most probable path here.
The MCRB price prediction for 2027 points to an average of $6.29 (low $4.86, high $8.68) — a potential gain of +25% on today's $5.03. Momentum favours further upside here.
In 2028, MCRB is projected to trade between $5.10 and $9.94, averaging $6.86 — a potential gain of +36% from today's $5.03. That is up +9% on the projected 2027 average. Buyers look set to stay in control over this stretch.
Seres Therapeutics, Inc.'s 2029 outlook centres on $6.81, within a $4.90 to $10.24 range. That is -1% versus the projected 2028 average. That marks a +35% change versus current levels. Momentum favours further upside here.
By 2030, MCRB could reach as high as $10.18, with a base case around $6.57 and support toward $4.59 — roughly +31% from $5.03. Buyers look set to stay in control over this stretch.
Expect MCRB to range from $4.14 to $9.70 through 2031. The $6.09 average target implies a +21% move from current prices. That is -7% versus the projected 2030 average. Momentum favours further upside here.
The MCRB price prediction for 2032 points to an average of $6.71 (low $4.45, high $10.94) — a potential gain of +33% on today's $5.03. Buyers look set to stay in control over this stretch.
In 2033, MCRB is projected to trade between $4.78 and $12.29, averaging $7.37 — a potential gain of +47% from today's $5.03. That is up +10% on the projected 2032 average. Momentum favours further upside here.
Seres Therapeutics, Inc.'s 2034 outlook centres on $8.13, within a $5.15 to $13.82 range. That is up +10% on the projected 2033 average. That marks a +62% change versus current levels. Buyers look set to stay in control over this stretch.
By 2035, MCRB could reach as high as $16.55, with a base case around $9.56 and support toward $5.93 — roughly +90% from $5.03. Momentum favours further upside here.
Expect MCRB to range from $5.91 to $19.65 through 2040. The $10.53 average target implies a +109% move from current prices. That is up +10% on the projected 2035 average. Buyers look set to stay in control over this stretch.
The MCRB price prediction for 2050 points to an average of $18.99 (low $8.88, high $39.49) — a potential gain of +278% on today's $5.03. Momentum favours further upside here.
Investing $1,000 in MCRB today (≈ 198.807157 MCRB) could be worth
$3,775.93
+$2,775.93 (+278%) by 2050 · US Dollar
Based on the average projected MCRB price of $18.99 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in MCRBwould be worth at today's price.
$1,000 invested in MCRB on Jul 31, 2025 (≈ 70.126226 MCRB) would be worth
$352.73
-$647.27 (-64.7%) today · 0.35× · US Dollar
Based on a MCRB entry price of $14.26 vs. today's $5.03.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $4.97 | $1,013.09 | +1.3% |
| 1 month ago | $7.94 | $633.5 | -36.6% |
| 3 months ago | $7.61 | $660.97 | -33.9% |
| 6 months ago | $15.15 | $332.01 | -66.8% |
| 1 year ago | $14.26 | $352.73 | -64.7% |
| All time (5.0y) ago | $139.6 | $36.03 | -96.4% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our MCRB forecast.
Our base-case forecast reaches $10.00 around 2040.
Implied market cap at $10.00: $96.84M
The multi-year forecast shows a bullish sentiment across the horizon, with years after 2026 generally indicating higher averages and positive returns.
Key milestones include 2026 with min $4.97, avg $4.97, max $6.68 (ROI 0; sentiment NEUTRAL) and 2027 onward showing rising averages and positive ROIs, culminating in 2030 with avg $6.61 and ROI 33.1, 2040 with avg $11.71 and ROI 135.9, and 2050 with avg $20.30 and ROI 308.9.
Overall, the outlook is bullish through 2031–2050, but these figures are estimates and not guarantees; actual results can differ due to market conditions and other factors.
Tap a question to reveal the answer.
The forecast lists min $4.47, avg $6.61, max $10.59 with ROI 33.1% and sentiment BULLISH.
The forecast shows bullish sentiment from 2027 onward with rising averages and ROIs up to 308.9% by 2050; however, these are estimates and not guaranteed.
Yes—the 2050 forecast lists avg $20.30 and max $44.64, indicating the potential to reach and exceed $20 by 2050.
The 30-day range is $3.78 to $6.52.
Current price is $4.97 and market cap is $48.08M; the rank is 4342.
Seres Therapeutics, Inc. Community Discussion
0Share your Seres Therapeutics, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.